Click www.fastfind.com

Benfotiamine - A New Tool In Preventing Diabetic Complications?


Benfotiamine made headlines globally in 2003 when researchers released information about a study that was conducted at The Einstein College of Medicine in New York. The bottom line of this study was that a substance of the allithiamine group of the naturally occurring thiamine-derived compounds had positive effects on neuropathy, retinopathy and nephropathy and heart/circulatory problems in diabetics.

Benfotiamine research has suggested that there are beneficial effects for diabetics and non-diabetics also. These benefits include sciatica, vascular health, general nerve health, lower blood pressure, grant cellular protection, anti-aging, fibromyalgia, prevention of lactic acidosis, and treatment for Alzheimer's disease. Any condition that is the result of a thiamine deficiency will also respond quite well to benfotiamine. Of course, any bodily function that is improved by a therapeutic level of thiamine will certainly be enhanced by benfotiamine, since benfotiamine is perhaps the most effective form of thiamine.

Benfotiamine, a derivative of thiamine (vitamin B1), was an invention of Japanese scientists and there is a U.S. patent on benfotiamine that was entered by the Japanese back in 1962. Japanese benfotiamine is considered the purest source of bulk benfotiamine and is favored by manufacturers globally who insist on the highest quality in their benfotiamine product.

The safety of benfotiamine use has been proven over 12 years of use in Europe for the treatment and prevention of diabetic complications among others. The original Japanese patent on benfotiamine gave information that it is even less toxic than common vitamin B1 (thiamine hydrochloride usually). Orally ingested vitamin B1 has a long history of use as an oral supplement without reported adverse effects. Due to its therapeutic action in some frequently observed clinical syndromes, thiamine hydrochloride has been advised and used over a long period of time. There are no reports of adverse effects of oral thiamine, even at dosages of several hundred milligrams a day (SCOGS, 1978; DHEW, 1979; Marks, 1989).

Benfotiamine has a very good safety record. To date, there has been no reports of any known, negative interactions with any medications. To the contrary, some medications actually can cause a thiamine deficiency in some people and benfotiamine could correct this serious situation.

Many researchers, medical experts, doctors, podiatrists and many medical publishers recommend benfotiamine for neuropathy, retinopathy nephropathy, heart/circulatory complications and B1 deficiencies. Any in depth study on the web will produce physicians, naturopaths, neurologists, optometrists, chiropractors, etc. who have very positive feelings about the effectiveness and potential of benfotiamine in terms of the research done to date on this important tool in the arsenal against neuropathy, retinopathy and beneficial for the heart and circulatory system. We have professional healthcare providers from all of these disciplines which shows the confidence the medical community has in the purity and bioavailability of our benfotiamine product.

Dr. David Williams, publisher of "Alternatives Newsletter", wrote an in depth article concerning benfotiamine in his May, 2004 issue. This article is an eye opener in terms of how effective benfotiamine can be for many health conditions. If possible, it would be beneficial for any interested reader to take a look at this article. For more information about this article you may contact the author below.

Dr Paul Chous is another medical professional who sees the merits of benfotiamine:

"I suspect strongly that benfotiamine will mitigate (or, hopefully, prevent) DRT in humans, but the burden of proof has not yet been met. The case for symptomatic relief of neuropathy symptoms is, of course, more tangible." http://www.emuhealthproducts.com/drchous.html

In conclusion, the consensus for benfotiamine is very positive and are worth investigating. If you or anyone you know is a diabetic, the great possibility of developing diabetic complications over time makes benfotiamine a viable tool in the arsenal for protection. If they are already experiencing complications such as neuropathy, retinopathy, and others, they will benefit from possible reduction in the progression along with pain relief in terms of peripheral neuropathy and other neuropathies.

Zach Malott is CEO of Brentwood Health International, a nutritional supplement company involved in distribution and supplying wholesale, retail and end users.

Mr. Malott is available to discuss the research as it applies to benfotiamine in the treatment and prevention of diabetic complications such as neuropathy and retinopathy.

He can be reached at:

Phone: 505.354.0526

Website: http://www.emuhealthproducts.com




Statement of the American Diabetes Association on Anniversary of ...
MarketWatch - 17 hours ago
The ADA is the nation's leading voluntary health organization supporting diabetes research, information and advocacy. The Association's advocacy efforts ...
Disabilities Act helps open the door, but not wide enough Asheville Citizen-Times
US Sen. Harkin: The Promise of the Americans with Disabilities Act IowaPolitics.com (press release)
all 15 news articles


Auto Racing Daily

Jack Perkins back to V8s after diabetes
Sydney Morning Herald, Australia - 6 hours ago
"Diabetes is something that you can manage and live with, and carry on a pretty normal life and that includes driving. "It was necessary at the time to take ...
Irwin Racing's Matt Halliday Spends Time With Soccer Superstar PaddockTalk
all 7 news articles


dBTechno

Twofold Action Urged for Pre-Diabetes
Washington Post, United States - Jul 23, 2008
Pre-diabetes occurs when blood sugar levels or impaired glucose tolerance is elevated, but not quite to the point defined as diabetes. ...
Pre-Diabetes Must Be Treated, Doctors Urge ABC News
Endocrinologists Issue Consensus Statement on Pre-Diabetes MedPage Today
Diabetes Experts Recommend One-Two Punch for Treating Patients ... MarketWatch
eMaxHealth.com - Chatter Shmatter
all 36 news articles


Diabetes story inspires hope
Toronto Star,  Canada - 4 hours ago
Type 1 diabetes, ever since, has demanded theirs and my full attention, day-by-day. Needless to say, living with the risks inherent in young children and ...
The Observer Sarnia Observer
all 2 news articles


Astra seeks approval for diabetes drug
Forbes, NY - Jul 23, 2008
The two companies began collaborating in January 2007 to develop and sell two investigational drugs for type 2 diabetes, saxagliptin and dapagliflozin. ...
Approval sought for diabetes drug The News Journal
Bristol-Myers Squibb and AstraZeneca Submit New Drug Application ... Business Wire (press release)
Bristol-Myers Squibb, AstraZeneca submit market clearance ... RTT News
Pharma Times (subscription) - PR-Inside.com (Pressemitteilung)
all 25 news articles


Ontario Now

Ontario Pledges $741 Million Against Diabetes, Including Funding ...
Diabetes Health (press release), CA - 12 hours ago
The provincial government of Ontario has announced it will spend $741 million over the next four years to combat diabetes, including paying the costs of ...
Diabetes expert lauds insulin pump coverage London Free Press
Hundreds of locals have Type 1 diabetes Orillia Packet & Times
Ontario to invest $741 million in diabetes treatment and prevention The Canadian Press
NorthernLife.ca - Medical News Today
all 74 news articles


First-line antihypertensive treatment in patientswith pre-diabetes ...
7thSpace Interactive (press release), NY - 9 hours ago
Recent clinical trials reported conflicting results on the reduction of new-onset diabetes using RAS blocking agents. Therefore the role of these agents in ...


NHS Choices

Fruit juice and type 2 diabetes
NHS Choices, UK - 21 hours ago
“Fruit juice ‘is diabetes risk’” is the headline in The Sun. “A daily glass of ‘healthy’ orange juice could actually increase the risk of diabetes,” the ...
Just one glass of orange juice a day could increase risk of diabetes Daily Mail
Fruit juice is diabetes risk The Sun
all 5 news articles


Miss Teen Diva Yamilka George to work with the BVI Diabetes ...
Platinum News Online, British Virgin Islands - 1 hour ago
The BVI Diabetes Association congratulates Ms. Yamilka George upon winning the coveted title of Miss Teen Diva 2008. Ms. George was crowned on July 12, ...


Antioxidants Improve Diabetes Complication
Medfinds, WA - 4 hours ago
By Kimberly Beauchamp, ND Healthnotes Newswire (July 24, 2008)—People with type 2 diabetes are more likely to suffer from memory problems, especially right ...

Diabetes - Google News

home | site map

© 2006 www.elearn-university.org